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I, INTRODUCTION 
Ammodytoxin A, formerly designated as the venom 
fraction ‘k2’ [lll. is the most basic and the PI~OSC 
prcsynaptically neurotoxic phospholipase AZ from the 
venom of the long-nosed viper, Vipera arnnrodyres am- 
nrodyres(i.v, LDM = 0,021 mg/kg). It is 28 times more 
Icthal than ammodytoxin B (i,v. LDsn = 0.58 mg/kg) 
and 17 times more lethal than ammodytoxin C (i.v. 
LDVJ = 0.36 mg/kg) [2]. Besides primary structures of 
ammodytoxins A, B and C [3-51 and the sequence of 
homologous protein fraction ‘1’ designated as am- 
modytin L (KriZaj et al., in preparation) on the protein 
level their cDNAs have also been sequenced [6-g]. All 
sequenced arnmodytoxins are composed of 122 amino 
acids. Amrnodytoxin A and ammodytoxin B differ in 
only three amino acids at positions 115, 118 and 119, 
whereas ammodytoxin A and ammodytoxin C differ in 
two amino acid residues at positions 124 and 128 
(numbering according to Renetsedcr et al. [lo]), Dif- 
ferences in the primary structure of ammodytin L are 
greater and it lacks neurotoxicity. Sequence data have 
provided some evidence for the location of the toxic site 
in ammodytoxin which disagrees with the predictions of 
this site in presynaptically active phospholipases 
[ll-141. 
In the present study two monoclonal antibodies were 
raised against native ammodytoxin A and polyclonal 
antibodies were raised against four synthetic peptides 
derived from different exposed regions of the molecule 
[IS]. The enzymatic and lethal activities of complexes 
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of arnmodytoxina with these antibodies revealed a so. 
far unsuspected part of the moteeular surface rcaponai- 
blr for neurotoxicicy, 
2. MATERIALS AND METHODS 
Ammodytaxin A was i$Olt\ted ;IS described earlier [I], DMEM 
mcdiunr, HAT and HT were from Flow Laboratories (UK), Fetal calf 
serum was supplied by Hy Clenc baborarorics (Utah). I-I~rrcrrdish 
pcroxidasc conjugates of goal antimouse IgG and IgG + IBM were 
obtained from Jackson Lmmunoresearch Laboroturirs (Avondalc, 
USA). Frcund’s complete and incomplete adjuvent and keyhole 
limpet hctnocyarrirr wcrcpctreharcd from Calbiochem (B&ring Corp., 
CA). PEG IS00 and human serum albunria (HSA) were from Scrva 
(l-ieidclberg), 2,2’.Azinobis (3.ethylbenrthiazalolircsulfonic acid 
(ABTS), bovine serum albumin (..iSA) and N-(-r- 
malcimidobutyryloxy)ruccinimide (GMBS) were obtained from 
Sigma Chemical Co. (Missouri). 0thcr reagents were of analytical 
grade. 
2. I, Preparafiotr of t~fotroclonul atlriboclies 
Female BALB/c mice were immunized subcutaneously with 0.7 pg 
of atnmodytoxin A in Frcund’s complete adjuvant (200 $/mouse) 
followed with the same dose 14 days later. Two weeks after the second 
injection, the same quantity of antigen in Freund’s incomplete adju- 
vant was injected lntraperitoneally. TVO weeks later (3 days before fu-. 
sion) the mice with the highest titer of antibodies were boosted i.v. 
with 0.S pg of ammodytoxin without adjuvant. 
Hybridomas were prepared in the usual manner [16,17] using 
X63-Ag8.653 myeloma cells [IQ. The presence of specific antibodies 
was assessed by ELISA. Positive hybridomas were cloned twice by 
limiting dilution [l9]. Ascites was produced by i.p. injection of 2 x 10’ 
hybridoma cells into pristane-primed BALWc mice, Ascites fluid was 
harvested, centrifuged and the supernatant stored at -. 20°C until use. 
Monoclonal antibodies were purified from the ascites by affinity 
chromatography on ammodytoxin C-Sepharose 4B [20]. The concen- 
tration of antibody was estimated by the absorbance at 280 nm assum- 
ing A’“lcn, = 14.0 and 11,8 for IgG and IgM, respectively. ELlSA 
was performed in microtiter plates. The wells were coated with the op- 
timal concentration of ammodytoxin A (2.5 &ml) or synthetic pep- 
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ridcx (20 p&/ml) ifi 0.01 M hydreticn carbonate bulfrr, gt I 9.6. Alter 
overnight incubation 111 4.C the wells were rinsed 3 times with 
phosphate-buffered saline (PBS), pl-1 7.2, containing O.OlsFp Twesn 
20. IQ0 ~1 of sample was applied IO each well and incubtwcd for 2 h 
at 37°C After incubation, the plates were again washed 3 times with 
PBS Twcen 20. IQ0 ~1 ol pcroxidasc Inbelled goat anti.mousc 
I@1 + Ighl at a dilution of I:5000 in 1% BSA wns added toeaeh well 
and inc\ibatcd for 2 h at 37’C. Alter weshiny, with PUS/Twccn 20, 
100 pl of 0. I% ARTS and 0.012t W&I1 in 0.01 M citrate phosphate 
buffer, pW 4,5, were added to the wells, After incubation for 30 min 
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Fig, 2, Binding curves of anti-Ll, anti-12, anti-13 and anti-L4 
polyclonal antibodies to ammodytoxin A, B and C in ELISA test. 
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81 37°C the absorbance was measured FII 410 nn using a Minircadzr 
II (Dynatcch, Drnkcndarn. 
Anriqcptide nntibodicx were rvrlscd rewards peptides correxpan. 
ding to the residues II&l2t (Ll), lOd-113 (L2), 70-W (L3) and 
123-133 (L41 (cf. Pigs I and 3), xynthekizcd by 0~s solid phase method 
[Zl). In the First three peptidrs an irdditiannl ryxteinc was added to the 
CWminu$ to allow the pepride to couple IO the protein carrier via the 
-St! yroup by GMBS 122,231. Polyclanal antibodies agninwt tour 
pepridc conjugates were preprrcd in rabbits by three subcu~~~cous in- 
jcclions into the feet at two-week intervals using KL# conjugntcs 
cmulsil%d in complete Preund’s adjuvant. The titer of specific nn- 
tibody was determined by ELI%. Antibodies wcrc purified from ~hc 
serum by affinity chromatography on protein A-Scpharose 48 124) 
followed by nffinity chromatography on ammodytoxin C-scpherosc 
4B [XI]. 
The binding of antibodies to isotoxins wns dctcrmined by ELlSA 
pcrformcd as above with the following modifictuions: 211 dilutions of 
antibodies in I% 13% were applied to the wells after ovcrniyht in- 
cubation with ammodytoxins A, B, C. After incubation for 2 h at 
37OC and washing with PBS-Twren, lOOpI of pcroxidasc labclled goat 
anti-rabbit IgG or IgG c tgM al dilution I:5000 in 1010 BSA was added 
to each well and incubated for 2 h at 37T. The subsequent steps were 
performed in the same way as above. 
Toxicity of immune complexes was assayed after monoclonal an- 
tibodies and monospccific polyclonal antibodies were incubated with 
3 i.p. L&o of ammodytoxin A in molar ratio 2.5:1 for 30 min at 
56OC. The mixture was injected i.p. to groups of 6 mice (25 6). Con. 
trols were injected only with ammodytoxin A or antibody. 
Phospholipasc activity of immune complexes and of ammodytoxin A 
was determined according to De Haas et al. [25]. 
3. R.E§ULTS AND DISCUSSION 
Because of the high toxicity of ammodytoxin A, the 
amount of antigen was limited during the immunization 
procedure which resulted in low titres of specific an- 
tibodies before the fusion. Three fusions were perform- 
ed to obtain monoclonal antibodies against he native 
ammodytoxin A giving a hybrid growth in 308 out of a 
total of 696 wells containing selective HAT medium. 
Seven wells were positive as determined by ELBA, but 
Tnblr I 0~ the toxlcJty of ammodytoxin A. Prtrm these results 
and from the fact that menocliannl ~nt~b~dj~~ KY&S 
bind to jiynthctie pcprida Ll and K3ll IB paptide t4 iru 
ELISA it fe~‘atlswx that bath nvansclcM ~nt~~~d~c~ np- 
pslrrntly bind to the e~rrqvxxlin~ part of the rurfactz 
en@ toxin. 
only two cell lines developed suitably and were cloned 
by the limiting dilution method. The finally chosen 
clones were designated as K321 and K326 and were 
grown i.p. in BhCB/e mice. Both cell liner proclueed 
only small amounts of antibodies which were purified 
from ascicic fluid by affinity chromatography on pro- 
tein A-Scpharose 4B and were identified as the IgGi and 
IgGz subclass. The pure monoclonal immunoglobulins 
G showed a family of bands on isoelectric focusing 
around @-I 6.55 (K32I) and 5.U (K326). 
The purity of site-specific polyclonal antibodies was 
determined by SDS-PAGE electrophoecsis and the 
specificity was established by ELISA, The binding of 
site specific potyclonal antibodies to ammodytoxins A, 
B and C is shown in Fig 2. Enzymatic activities and 
toxicities of the comp1exe.s of antibodies with am- 
modyroxin A are shown in Table I. Monoclonal an- 
tibody K321 did not neutralize the toxicity or affect en- 
zymatic activity of ammodytoxin A even when added in 
IO-fold excess, whereas antibody K326 in molar ratio 
2.5: 1 completely abolished the toxicity, resulting in the 
survival of all 6 tested ammals. 
Polyclonal antibodies against he four synthetic pep- 
tides (LI, L2, L3, L4) (Fig. 3) had different effects on 
the toxicity of ammodytoxin A (Table I). Antibodies 
against L2 totally and against Ll partially blocked the 
toxicity. Antibodies against L3 and L4 had no influence 
Polyclon.aI antibodies agwinxt peptidca I.2 and LT 
lowered the pt~~splloli~~s~ artivity by 25 and 64%, 
respectively (Table I) although tRc binding of later an- 
ti.bodics is rather wenk, Anribsdiex rg;ainst L1 and t4 
had no clf’eet cm the phospholipase activity of immune 
eamplexes. The binding of palyslon~l anti-peptide (L1: 
to L41 antibodies to the three rmmsdyroxinx essentially 
esrrcspondo to differences in rho primary structures of
these proteins (Fig. 3). Exceptional is the slightly better 
ammodytoxin C binding of anti-peptide Ll and weaker 
binding of anti-peptide L2 antibodies, This could be ex- 
plained by sterie effects in ELISA where the orientation 
of wall-bound ammodytoxin C allows different ex- 
posures of binding site. 
According to our results, it seems that in am- 
modytoxlns the toxic site comprises a part of the 
primary structure corresponding to pcptides Ll and L2 
where several basic amino acids are located. Several 
authors have studied the structure of different oxins by 
an immunological approach, but only some were suc- 
cessful in obtaining monoclonal antibodies having 
neutralization patencial gainst intact toxins and known 
binding characteristics, Boulain and co-workers 
prepared monoclonal antibodies against Nu@ 
nigricnllis toxin-a [26] but the epitope was 
topographically distinct from the ‘toxic’ site of toxin. 
Monoclonal antibodies against P-bungarotoxin partial- 
ly inhibited its phospholipase activityand did not pro- 
tect against he lethal effects of the toxin, although they 
doubled the time to death with respect to control 
animals [27]. Rae1 et al. prepared monoclonal an- 
tibodiss against Mojave toxin [28] specific for the basic 
subunit, but they neutralized neither the toxicity nor the 
phospholipase A2 activity of Mojavc toxin. Kaiser and 
Middlebrook, however, reported on crotoxin neurraliz- 
ing monoclonal antibody raised against the basic 
subunit of crotoxin 1291. 
NEUROTOXIC PHOSPHOLIPASEY A2 FROM VIPEAA RMMODYTES VENOM --. 
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Fig. 3. The primary structures of ammodytoxin A, I3 and C, Position of four synthetic peptides used for raising the antibodies is indicated. 1.~. 
L&O for white mice is in mg/kg. 
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Tl~e use or antibodies atlainsl  peptides derived rrom 
the primary structure have proved to be a us©rui tool in 
the study or structure function relationship o f  
neurotoxins. Accordin8 to our results, the surface 
rei l ion o f  ammodytoxin A which binds to neutral iz ing 
~ntibodies is part of  a continuous epitope correspon- 
d ing to  peptlde L2 (106-113), It would thus be possible 
to use this epitope as a vaccine. It was also shown that 
at least part of' the ammodytoxin A toxic (or receptor 
binding) site is located in or near the sequence 106-113 
(Fill, 2), which is a highly exposed part of' the molecule 
located outs ide the areas where toxic sites in p resynapt ic  
neurotoxins were predicted by comparison of  known 
pr imary structures.  
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